The product descriptions on this website are for offering information only. Challenge We are looking for talents who face challenges head-on, embrace changes, and are not afraid to fail.
As a result, the site may contain information on pharmaceuticals and other products or uses of those products that are not approved in other countries or regions.Celltrion Healthcare provides this link as a courtesy and does not control the content192315510900-433db52a-a7a0-4c0b-b096-e9468ceef9aa.jpgVous quittez maintenant le site Web de Celltrion Healthcare.You are now leaving the Celltrion Healthcare website.We are exerting efforts to achieve sustainable growth.The world's first subcutaneous Oversee global clinical trial operations (IND application, patient recruitment, and CRO management) Maintain and improve clinical trial quality (clinical trial provider monitoring, etc.) They are not intended for promoting PR or sales campaigns. The product descriptions on this website are for offering information only.
Interview Technical interviews and personality interviews with executives * Interviews may be conducted in English or non-Korean languages for positions requiring language skills. If anyone holding himself/herself out as a representative or recruiter for Celltrion Healthcare asks for a reservation or holding fee or states that you need to pay for training or security checks, please be extremely careful.
Employment: Submit Application Online application only: Interview Interviews and competency / personality trait assessments are conducted * Interviews may be conducted in English or other languages for some positions.
They are not intended for promoting PR or sales campaigns. 「医療関係者の皆様へ」のページでは当社医療用医薬品を適正にご使用いただくため、国内の医療関係者の方を対象に情報を提供しています。一般の方に対する情報提供を目的としたものではないことをご了承ください。
infliximab biosimilarEuropean Commission grants marketing authorisation for world’s first subcutaneous formulation of infliximab, Remsima® SC, for an additional five indicCelltrion Launches Human Clinical Trial of Potential COVID-19 Antiviral Antibody Treatment Following Positive Pre-Clinical ResultsCelltrion Healthcare receives positive CHMP opinion for an additional five indications for Remsima® SC including for use in inflammatory bowel diseaseCelltrion to expand COVID-19 testing portfolio to include both antigen and antibody testing kitsOffers of employment or job openings with requests for payment of fees are fraudulent. Celltrion Healthcare and its recruiters NEVER ask for money from prospective employees for such purposes, nor do we charge a fee at any stage of the recruitment process, including application, interview meeting, processing, training, or any other fees.If you have questions or concerns about the suspicious job offer, please click the following to contact us.
The product descriptions on this website are for offering information only. 「医療関係者の皆様へ」のページでは当社医療用医薬品を適正にご使用いただくため、国内の医療関係者の方を対象に情報を提供しています。一般の方に対する情報提供を目的としたものではないことをご了承ください。
1. The Celltrion Healthcare Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. They are not intended for promoting PR or sales campaigns. As a result, the site may contain information on pharmaceuticals and other products or uses of those products that are not approved in other countries or regions.Celltrion Healthcare provides this link as a courtesy and does not control the contentVous quittez maintenant le site Web de Celltrion Healthcare.You are now leaving the Celltrion Healthcare website. The product descriptions on this website are for offering information only. They are not intended for promoting PR or sales campaigns. They are not intended for promoting PR or sales campaigns. For more details on pharmaceuticals, please consult a doctor or a medical specialist. Celltrion Healthcare offers biologics to circa 100 countries working with more than 30 global partners. Principle We are looking for talents who value life, fulfill responsibilities, and uphold principles. With hands-on experience and knowledge accumulated through years of working in the advanced pharmaceutical markets of the United States and Europe, Celltrion Healthcare has been securing distribution channels and providing patients with biosimilars at affordable prices.Celltrion Healthcare has become the world’s leading company that specializes in biologics by offering high-quality biosimilars to about 110 countries, with the ultimate goal of promoting the welfare of humanity.
The product descriptions on this website are for offering information only.
Celltrion Healthcare offers biologics to about 110 countries, along with more than 30 global partners around the world. Celltrion Healthcare fournit ce lien à titre gracieux et ne contrôle pas le contenu